Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Patent
1997-03-03
1999-10-19
Saunders, David
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
530820, C07K 14705
Patent
active
059691026
ABSTRACT:
A novel lymphocyte receptor protein, its DNA sequence, and its role in the calcium activation pathway is described. The protein, or genetically engineered constructs encoding it, are shown to increase lymphocyte response, and to identify ligands of the protein receptor. Antibodies to the proteins of the invention are generated for diagnostic therapeutics. The protein and DNA can also be used for diagnostic purposes and for identifying agents for modulating the calcium induced activation pathway. A particular advantage of the present invention is that it provides lymphocyte activation of receptor found on all B cells, but only on a subset of T cells. The receptor can thus be targeted to specifically regulate B cell responses without affecting mature T cell activity. Such targeting specificity is always advantageous, particularly where an increase or decrease of antibody production is desired, e.g., during an infection (increase) or to avoid immune complex deposition complications (rheumatoid arthritis, glomerulonephritis, and other auto immune conditions).
REFERENCES:
patent: 5523227 (1996-06-01), Bram et al.
patent: 5541291 (1996-07-01), Keene
Birren et al. (1998) Sequence Database: AC003958.
Holloway et al. (1996) J. Biol. Chem. 271:8549-52.
Tashiro et al. (1993) Science 261:600-3.
von Bulow et al. (1997) Science 278:138-41.
von Bulow et al. (1997) Blood 90:246A-7.
Bairoch, Nucl. Acids Res., 21:3097-3103 (1993).
Bram & Crabtree, Nature, 371:355-358 (1994).
Bram et al., Mol. Cell. Biol., 13:4760-4769 (1993).
Clipstone and Crabtee, Nature, 357:695-7 (1992).
Crabtee & Clipstone, Annu. Rev. Biochem., 63:1045-1083 (1994).
Emmel et al., Science, 246:1617-1620 (1989).
Fiering et al., Genes Dev., 4:1823-1834 (1990).
Friedman & Weissman, Cell, 66:799-806 (1991).
Holloway & Bram, Biol. Chem., 271:8549-8552 (1996.
Hoth & Prenner, Physiol., 465:359-386 (1993).
Imboden et al., Immunol., 134:663-665 (1985).
Karttunen & Shastri, Proc. Natl. Acad. Sci. USA, 88:3972-3976 (1991).
Liu et al., Cell, 66:807-15 (1991).
O'Keefe et al., Nature, 357:629-4 (1992).
Premack et al., J. Immunol., 152:5226-5240 (1994).
Putney & Bird, Cell, 75:199-201 (1993).
Takebe, Y., et al., Mol. Cell. Biol., 8:466-472 (1988).
Truneh et al., Nature, 313:318-321 (1985).
Verweij et al., J. Biol. Chem., 265:15788-15795 (1990).
Weiss & Littman, Cell, 76:263-274 (1994).
Zweifach & Lewis, Proc. Natl. Acad. Sci. USA, 90:6295-6299 (1993).
Bram Richard J.
Von Bulow Gotz
Saunders David
St. Jude Children's Research Hospital
VanderVegt F. Pierre
LandOfFree
Lymphocyte surface receptor that binds CAML, nucleic acids encod does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Lymphocyte surface receptor that binds CAML, nucleic acids encod, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lymphocyte surface receptor that binds CAML, nucleic acids encod will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2056797